++ cologuard cpt code

["618.86"]

Understanding the Screening Options from the new USPSTF Colorectal Ca… | cologuard cpt code

Image Source:

cologuard cpt code

In a address appear Tuesday, Mizuho analyst Peter Lawson common a Buy appraisement and amount ambition of $35 on EXACT Sciences Corporation (NASDAQ: EXAS). Two announcements, accepted in the fall, are accepted to drive Cologuard acceptance further.

["618.86"]

Understanding the Screening Options from the new USPSTF Colorectal Ca… | cologuard cpt code

Image Source:

The analyst expects the USPSTF abstract admonition and the CMS/CPT cipher cross-walking announcements to be positive. "The Cologuard barrage is advanced calmly and we accept acumen into abutting division with 3Q analysis admonition ahead announced," Lawson stated.

The aggregation appear its 2Q15 results, with operating costs hardly aloft the estimates and gross margins advisedly assault expectations.

["641.17"]

Discoveries in Health Policy: CMS Releases Prices for New CPT CLFS ... | cologuard cpt code

Image Source:

With the USPSTF colon blight screening abstract admonition accepted in 3Q15, the analyst believes that an "A" or "B" appraisement for Cologuard would advance to binding clandestine allowance coverage, as able-bodied as admittance of Cologuard in affection programs for appraisement bloom affairs and physicians.

The analyst additionally believes that a "B-" appraisement is absurd and would accomplish it difficult for the aggregation to drive the use of Cologuard, abnormally amid beyond bloom systems.

["892.4"]

CMS Issues Preliminary Determination Maintaining Cologuard ... | cologuard cpt code

Image Source:

"We additionally apprehend a accommodation from CMS on the cross-walking of Cologuard's G-code to a CPT cipher from the AMA, which would acceptable access in the affluence of accession agreement and enhance uptake. We apprehend the bridge to be implemented at accepted pricing," the Mizuho address said.

Latest Ratings for EXAS

["618.86"]